Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of lipid lowering effects of rosuvastatin and atorvastatin in type 2 diabetic patients with hyperlipidemia
TCTR20260527011Phase 4Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- May 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in type 2 diabetes mellitus (T2DM) and hyperlipidemia comparing Rosuvastatin arm with Atorvastatin arm (2 arms). Primary endpoint: Primary lipid-lowering effect. Started May 2026; status: completed.
02
Drugs
rosuvastatinatorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)hyperlipidemia
Beyond the preview
Go deeper on TCTR20260527011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260527011.